Vernakalant

Vernakalant (INN; codenamed RSD1235, proposed tradenames Kynapid and Brinavess) is an investigational drug under regulatory review for the acute conversion of atrial fibrillation. It was initially developed by Cardiome Pharma, and the intravenous formulation was bought for further development by Merck in April 2009. In September 2012, Merck terminated its agreements with Cardiome and has consequently returned all rights of the drug back to Cardiome.

单词	Vernakalant
释义	Vernakalant 英语百科 Vernakalant Vernakalant (INN; codenamed RSD1235, proposed tradenames Kynapid and Brinavess) is an investigational drug under regulatory review for the acute conversion of atrial fibrillation. It was initially developed by Cardiome Pharma, and the intravenous formulation was bought for further development by Merck in April 2009. In September 2012, Merck terminated its agreements with Cardiome and has consequently returned all rights of the drug back to Cardiome.
随便看	splithead split headphone split headphones split heads split heating split heel incision split here split her sides split her sides with laugher split her sides with laughter split her vote split her votes split hides split His bundle potentials split His deflection split his sides split his sides with laugher split his sides with laughter split his vote split his votes split holder split hopkinson bar Split hopper barge split hopper dredger Split Horizon